Skip to content

The Value of Dynamic Monitoring of immune markers in the pneumonia of viral infection

The Value of Dynamic Monitoring of immune markers in the pneumonia of viral infection

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037695
Enrollment
Unknown
Registered
2020-08-30
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pneumonia

Interventions

severe pneumonia, mild pneumonia and healthy controls :collect the blood

Sponsors

Huashan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Severe pneumonia: 1. Patients with newly developed cough, expectoration, or aggravation of original respiratory diseases, and purulent sputum with or without chest pain; 2. Patients with fever; 3. Patients with pulmonary consolidation signs or moist rales; 4. WBC > 10 * 10^9 / L or 7 mmol / L, 1 point; respiratory rate >= 30 times / min, 1 point; systolic blood pressure = 65 years old, 1 point; curb 65 >= 3 points, diagnosed as severe pneumonia. Mild pneumonia: 1. Patients with newly developed cough, expectoration, or aggravation of original respiratory diseases, and purulent sputum with or without chest pain; 2. Patients with fever; 3. Patients with pulmonary consolidation signs or moist rales; 4. WBC > 10 * 10^9 / L or < 4 * 10^9 / L, with or without nuclear left shift; 5. Chest X-ray examination showed patchy, infiltrative shadow or interstitial changes, patients with or without pleural effusion, or showed new inflammatory lesions compared with the previous X-ray films; 6. Patients with the same pathogen isolated from BALF or deep sputum for two consecutive times, or proved by immunological methods, or with histopathological evidence and imaging findings; 7. Clinical diagnosis can be established for patients who meet any one of 1-5 plus item 6, and exclude lung tumor, interstitial lung disease, pulmonary edema, atelectasis, pulmonary embolism, pulmonary eosinophilic infiltration, pulmonary vasculitis, etc. 8. Patients with mild pneumonia were diagnosed with curb 65 score of 0-2. Healthy control (HC): the inclusion criteria were no clinical manifestations and imaging evidence of pulmonary infection, no previous immunosuppressive disease, no diabetes mellitus, and no use history of immunosuppressive agents in the past 6 months.

Exclusion criteria

Exclusion criteria: 1. Patients younger than 18 years old and over 80 years old; 2. Patients with severe coagulation or hemolysis in the sample; 3. Incorrect sample collection or storage objects; 4. The sample did not complete the evaluation according to the plan.

Design outcomes

Primary

MeasureTime frame
Immune markers;

Countries

China

Contacts

Public ContactGao Yan

Huashan Hospital Affiliated to Fudan University

ygao10@163.com+86 18702117801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026